Bodyport

Bodyport is a digital therapeutics company focused on empowering individuals to manage complex chronic conditions, particularly heart failure. The company integrates a sophisticated biomarker platform into user-friendly, at-home devices that noninvasively measure a wide range of hemodynamic biomarkers. This allows patients and their care teams to better predict, understand, and intervene in changes to heart health, ultimately reducing hospital visits and improving overall health outcomes. Bodyport serves patients with chronic conditions and operates in the healthcare market. The business model revolves around providing actionable health insights through its proprietary platform, generating revenue from device sales and potentially subscription-based services for ongoing health monitoring.

Keywords: digital therapeutics, chronic conditions, heart failure, biomarker platform, at-home devices, hemodynamic biomarkers, health insights, patient care, healthcare market, noninvasive measurement.